Adicet Bio, Inc.
ACET
$0.6653
-$0.0057-0.85%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -28.73M | -30.48M | -29.90M | -28.02M | -29.49M |
| Total Depreciation and Amortization | 1.62M | 1.59M | 1.60M | 1.65M | 1.69M |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 0.00 | 39.00K | 1.00K |
| Total Other Non-Cash Items | 3.21M | 7.30M | 6.80M | 6.46M | 5.67M |
| Change in Net Operating Assets | -206.00K | -420.00K | -1.92M | -2.98M | -1.36M |
| Cash from Operations | -24.10M | -22.01M | -23.42M | -22.85M | -23.49M |
| Capital Expenditure | -176.00K | -401.00K | -302.00K | -239.00K | -136.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -118.12M | -- | -- | -- | -- |
| Cash from Investing | -118.30M | -401.00K | -302.00K | -239.00K | -136.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 96.32M | 0.00 | 204.00K | 111.11M | 157.00K |
| Repurchase of Common Stock | -- | -96.18M | 0.00 | -141.00K | -81.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 96.32M | -96.18M | 204.00K | 110.97M | 76.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.08M | -118.59M | -23.52M | 87.88M | -23.55M |
